Biophytis SA banner

Biophytis SA
PAR:ALBPS

Watchlist Manager
Biophytis SA Logo
Biophytis SA
PAR:ALBPS
Watchlist
Price: 0.027 EUR -10% Market Closed
Market Cap: €2.5m

Biophytis SA
Investor Relations

Biophytis SA is a holding company. The company is headquartered in Paris, Ile-De-France and currently employs 24 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Stanislas Veillet Ph.D.
Chairman of the Board & CEO
No Bio Available
Mr. Waly Dioh Ph.D.
Chief Clinical Operating Officer
No Bio Available
Dr. Pierre J. Dilda Ph.D.
Chief Scientific Officer
No Bio Available
Dr. Rene Lafont
Scientific Advisor & Member of Scientific Advisory Board
No Bio Available
Dr. Rob van Maanen FFPM, M.B.A., M.D.
Chief Medical Officer
No Bio Available
Mr. Edouard Bieth
Chief Business Officer
No Bio Available
Ms. Chiara Baccelli
Chief Pharmaceutical Operations Officer & Quality Assurance Director
No Bio Available
Ms. _ Teylan
Financial Controller
No Bio Available

Contacts

Address
ILE-DE-FRANCE
Paris
14 avenue de l'Opera
Contacts
+33141836600.0
www.biophytis.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett